Erlotinib docked on EGFR tyrosine kinase. H-bonds (green) and pi interactions (purple lines) with the mapping surface showing erlotinib occupying the active pocket of EGFR tyrosine kinase.

 
 
  Part of: Alsaad H, Kubba A, Tahtamouni LH, Hamzah AH (2022) Synthesis, docking study, and structure activity relationship of novel anti-tumor 1, 2, 4 triazole derivatives incorporating 2-(2, 3- dimethyl aminobenzoic acid) moiety. Pharmacia 69(2): 415-428. https://doi.org/10.3897/pharmacia.69.e83158